Particularly, serum VEGF-A was significantly reduced during the early phase in AIS patients, and its levels tend to increase over periods ranging from hours to days post-stroke [23], inversely paralleling the decrease of miRNA-195-5p and miRNA-451a levels. This evidence concerns the gene VEGFA and Stroke.